IDSA: No Recommendations for COVID-19 Treatment for Now

0
256

[ad_1]
covid

Interim guidance from the IDSA recommends hydroxychloroquine/chloroquine in the context of a clinical trial and hydroxychloroquine/chloroquine plus azithromycin only’ in context of a clinical trial.

[ad_2]